Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
What is the annual incidence of NAION in individuals over 50
Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration
However, and like most grey market peptides, CJC-1295 did not succeed its clinical trial, and hence never became an official drug
You may have relevant information if you: Purchased sublingual compounded tirzepatide tablets, tirzepatide chewing gum, or any oral tirzepatide product from The Wellness Company (twc.health) Received a compounded tirzepatide product in tablet, oral, sublingual, gum, liquid, or drops form through The Wellness Company or one of its partnered pharmacies Were told or led to believe that The Wellness Company oral tirzepatide product was equivalent to Mounjaro, Zepbound, or another FDA-approved GLP-1 medication Did not experience meaningful weight loss while taking the product Paid significant out-of-pocket costs for the product Experienced side effects or quality concerns with a The Wellness Company oral tirzepatide product If You Purchased Oral Tirzepatide Tablets, Tirzepatide Gum, or Another Oral Tirzepatide Product from The Wellness Company, We Want to Hear from You If you purchased sublingual tirzepatide tablets or tirzepatide gum from The Wellness Company, or received tirzepatide in oral form dispensed through one of The Wellness Companys partnered pharmacies, we would like to speak with you about your experience
In our opinion, this is mainly due to the fact that many laboratory-stage techniques are limited by safety and ethical concerns
x Na M.W
